These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 25546558)

  • 1. Progression of gait dysfunction in incident Parkinson's disease: impact of medication and phenotype.
    Galna B; Lord S; Burn DJ; Rochester L
    Mov Disord; 2015 Mar; 30(3):359-67. PubMed ID: 25546558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor phenotype classification in moderate to advanced PD in BioFIND study.
    Luo L; Andrews H; Alcalay RN; Poyraz FC; Boehme AK; Goldman JG; Xie T; Tuite P; Henchcliffe C; Hogarth P; Amara AW; Frank S; Sutherland M; Kopil C; Naito A; Kang UJ
    Parkinsonism Relat Disord; 2019 Aug; 65():178-183. PubMed ID: 31255537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
    Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting dopa-sensitive and dopa-resistant gait dysfunction in Parkinson's disease: selective responses to internal and external cues.
    Rochester L; Baker K; Nieuwboer A; Burn D
    Mov Disord; 2011 Feb; 26(3):430-5. PubMed ID: 21462258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gait variability in Parkinson's disease: an indicator of non-dopaminergic contributors to gait dysfunction?
    Lord S; Baker K; Nieuwboer A; Burn D; Rochester L
    J Neurol; 2011 Apr; 258(4):566-72. PubMed ID: 21052710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-dopaminergic treatments for motor control in Parkinson's disease.
    Fox SH
    Drugs; 2013 Sep; 73(13):1405-15. PubMed ID: 23917951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation between cognition and motor dysfunction in drug-naive newly diagnosed patients with Parkinson's disease.
    Domellöf ME; Elgh E; Forsgren L
    Mov Disord; 2011 Oct; 26(12):2183-9. PubMed ID: 21661051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 12-year population-based study of freezing of gait in Parkinson's disease.
    Forsaa EB; Larsen JP; Wentzel-Larsen T; Alves G
    Parkinsonism Relat Disord; 2015 Mar; 21(3):254-8. PubMed ID: 25603767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-motor symptoms and quality of life in tremor dominant vs postural instability gait disorder Parkinson's disease patients.
    Wu Y; Guo XY; Wei QQ; Ou RW; Song W; Cao B; Zhao B; Shang HF
    Acta Neurol Scand; 2016 May; 133(5):330-7. PubMed ID: 26195131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recuperation of slow walking in de novo Parkinson's disease is more closely associated with increased cadence, rather than with expanded stride length.
    Kwon KY; Lee HM; Kang SH; Pyo SJ; Kim HJ; Koh SB
    Gait Posture; 2017 Oct; 58():1-6. PubMed ID: 28692855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Cognitive Decline Related to the Motor Phenotype in Parkinson's Disease.
    Michels J; van der Wurp H; Kalbe E; Rehberg S; Storch A; Linse K; Schneider C; Gräber S; Berg D; Dams J; Balzer-Geldsetzer M; Hilker-Roggendorf R; Oberschmidt C; Baudrexel S; Witt K; Schmidt N; Deuschl G; Mollenhauer B; Trenkwalder C; Liepelt-Scarfone I; Spottke A; Roeske S; Wüllner U; Wittchen HU; Riedel O; Kassubek J; Dodel R; Schulz JB; Costa AS; Reetz K
    J Parkinsons Dis; 2022; 12(3):905-916. PubMed ID: 35068416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants.
    Fasano A; Romito LM; Daniele A; Piano C; Zinno M; Bentivoglio AR; Albanese A
    Brain; 2010 Sep; 133(9):2664-76. PubMed ID: 20802207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor attentional function predicts cognitive decline in patients with non-demented Parkinson's disease independent of motor phenotype.
    Taylor JP; Rowan EN; Lett D; O'Brien JT; McKeith IG; Burn DJ
    J Neurol Neurosurg Psychiatry; 2008 Dec; 79(12):1318-23. PubMed ID: 18586866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of freezing of gait on functional dependency in Parkinson's disease with regard to motor phenotype.
    Santos-García D; de Deus-Fonticoba T; Suárez Castro E; M Aneiros Díaz Á; Feal-Painceiras MJ; Paz-González JM; García-Sancho C; Jesús S; Mir P; Planellas L; García-Caldentey J; Caballol N; Legarda I; Hernández-Vara J; González-Aramburu I; Ávila-Rivera MA; Catalán MJ; Nogueira V; Álvarez-Sauco M; Vela L; Escalante S; Cubo E; Sánchez-Alonso P; Alonso-Losada MG; López-Ariztegui N; Martinez-Martin P;
    Neurol Sci; 2020 Oct; 41(10):2883-2892. PubMed ID: 32333181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levodopa Is a Double-Edged Sword for Balance and Gait in People With Parkinson's Disease.
    Curtze C; Nutt JG; Carlson-Kuhta P; Mancini M; Horak FB
    Mov Disord; 2015 Sep; 30(10):1361-70. PubMed ID: 26095928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of motor and nonmotor features of Parkinson's disease and their response to treatment.
    Vu TC; Nutt JG; Holford NH
    Br J Clin Pharmacol; 2012 Aug; 74(2):267-83. PubMed ID: 22283961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do cognition and other non-motor symptoms decline similarly among patients with Parkinson's disease motor subtypes? Findings from a 5-year prospective study.
    Arie L; Herman T; Shema-Shiratzky S; Giladi N; Hausdorff JM
    J Neurol; 2017 Oct; 264(10):2149-2157. PubMed ID: 28879438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies.
    Burn DJ; Rowan EN; Allan LM; Molloy S; O'Brien JT; McKeith IG
    J Neurol Neurosurg Psychiatry; 2006 May; 77(5):585-9. PubMed ID: 16614017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonmotor features of Parkinson's disease subtypes.
    Marras C; Chaudhuri KR
    Mov Disord; 2016 Aug; 31(8):1095-102. PubMed ID: 26861861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in Language Function Correlates with Gait Improvement in Drug-naïve Parkinson's Disease Patients Taking Dopaminergic Medication.
    Murakami H; Momma Y; Nohara T; Mori Y; Futamura A; Sugita T; Ishigaki S; Katoh H; Kezuka M; Ono K; Miller MW; Kawamura M
    J Parkinsons Dis; 2016; 6(1):209-17. PubMed ID: 26889633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.